Why Cancer?
- PMID: 27194312
- PMCID: PMC4901109
- DOI: 10.1007/s40273-016-0413-0
Why Cancer?
Comment on
-
Cancer Drugs Fund 2.0: A Missed Opportunity?Pharmacoeconomics. 2016 Jul;34(7):629-33. doi: 10.1007/s40273-016-0403-2. Pharmacoeconomics. 2016. PMID: 27002519 No abstract available.
References
-
- McCabe C, Paul A, Fell G, Paulden M. Cancer drugs fund 2.0: a missed opportunity? Pharmacoeconomics. Epub 22 March 2016. - PubMed
-
- Claxton K, Martin S, Soares M, et al. Methods for the estimation of the NICE cost effectiveness threshold. CHE Research Paper 81. York: University of York, Centre for Health Economics; 2013.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources